Answers are grounded in this paper and cite their sources.
Physiologic and pathologic cardiac hypertrophy are driven by distinct molecular signaling pathways, providing potential targets for therapeutic intervention.
In broad terms, there are 3 types of cardiac hypertrophy: normal growth, growth induced by physical conditioning (i.e., physiologic hypertrophy), and growth induced by pathologic stimuli. Recent evidence suggests that normal and exercise-induced cardiac growth are regulated in large part by the growth hormone/IGF axis via signaling through the PI3K/Akt pathway. In contrast, pathological or reactive cardiac growth is triggered by autocrine and paracrine neurohormonal factors released during biomechanical stress that signal through the Gq/phospholipase C pathway, leading to an increase in cytosolic calcium and activation of PKC. Here we review recent developments in the area of these cardiotrophic kinases, highlighting the utility of animal models that are helping to identify molecular targets in the human condition.
No takes yet. Share an insight, caveat, or question.
Dorn et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: